Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of rhIGF-1 in Children with Primary IGFD
NCT00330668Phase 3Terminated
- Sponsor
- Ipsen
- Start
- Nov 2005
- Primary completion
- Feb 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of mecasermin in primary insulin-like growth factor-1 deficiency (PIGFD), sponsored by Ipsen. Started Nov 2005; status: terminated.
02
Drugs
mecasermin
03
Conditions
primary insulin-like growth factor-1 deficiency (PIGFD)
Beyond the preview
Go deeper on NCT00330668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330668.